• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS INSULIN; IMMUNOREACTIVE INSULIN TEST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS INSULIN; IMMUNOREACTIVE INSULIN TEST SYSTEM Back to Search Results
Model Number INSULIN
Device Problems Incorrect Measurement (1383); Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/01/2022
Event Type  malfunction  
Manufacturer Narrative
The sample was requested for investigation.
 
Event Description
The initial reporter stated they received questionable results for one patient sample tested with the elecsys insulin assay on a cobas 6000 e601 module, serial number (b)(4).The result did not agree with the patient's clinical manifestation and the values measured using a competitor method.The sample initially resulted in an insulin value of 11.31 uu/ml and repeated as 11.47 uu/ml on a second e601 module.The sample values were reported outside of the laboratory to the doctor and questioned.The sample was then repeated using a competitor method, resulting in an insulin value of 300 uu/ml.
 
Manufacturer Narrative
The last calibration with lot 590959 was performed on 22-sep-2022.Per product labeling: "renewed calibration is recommended as follows: after 1 month (28 days) when using the same reagent lot" quality control results were within specified ranges.The sample was provided for investigation.The customer's elecsys insulin result could be reproduced.Elecsys c-peptide was also tested and resulted in a similar value as obtained by the customer.Both values fit clinically together as within or close to the expected value range.The elecsys insulin and c-peptide results are considered correct.The investigation could not identify a product problem.Medwatch fields a2, a3 and b7 have been updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS INSULIN
Type of Device
IMMUNOREACTIVE INSULIN TEST SYSTEM
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key16019356
MDR Text Key308528736
Report Number1823260-2022-04122
Device Sequence Number1
Product Code CFP
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K001104
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 02/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/20/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2023
Device Model NumberINSULIN
Device Catalogue Number12017547122
Device Lot Number00633436
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/06/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age32 YR
Patient SexMale
-
-